| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1 |
| 1 | ALEMTUZUMAB | 1 |
| 2 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 |
| 3 | PANTOPRAZOLE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 1 | ALEMTUZUMAB | 1 | 0.0001 |
| 2 | PANTOPRAZOLE | 1 | 0.0000 |
| 3 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |